Aquilo Capital Management

Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:

Portfolio Holdings for Aquilo Capital Management

Companies in the Aquilo Capital Management portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
SPDR S&P; Biotech (XBI) 30.18 1.00M -20% 77.44
Uniqure Nv shs 9.28 501975 +26% 47.45
Dicerna Pharmaceuticals 8.86 1.24M +101% 18.37
Anaptysbio Inc Common 7.92 1.44M NEW 14.13
Xenon Pharmaceuticals 6.63 1.50M +28% 11.34
Spero Therapeutics Inc 5.73 1.82M +57% 8.08
Proqr Thrapeutics N V shs euro 5.14 2.40M +24% 5.49
Ngm Biopharmaceuticals Inc 5.03 1.05M NEW 12.33
Pieris Pharmaceuticals 4.95 5.58M +12% 2.28
Arrowhead Pharmaceuticals 4.89 436514 NEW 28.77
Merus N V 3.63 770183 -25% 12.10
Regenxbio Inc equity us cm 3.45 273211 32.38
Galapagos Nv-spon 3.38 44234 -38% 195.91
Morphosys Ag Adr 0.92 95898 +1477% 24.57

Past Filings by Aquilo Capital Management

View past SEC 13F filings by Aquilo Capital Management

View all filings